Brief: BioLife Solutions Q1 Revenue USD 21.6 Million Vs. IBES Estimate USD 22.2 Million
May 08 (Reuters) - BioLife Solutions Q1 adjusted net income USD 1.7 million vs. IBES estimate USD -2.59 million. Q1 adjusted operating income USD 900 thousand vs. IBES estimate USD -2.56 million Q1 adjusted gross margin 66% Q1 net income USD -400 thousand Q1 gross margin 63% outlook FY revenue USD 95.5-99 million
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary